Showing results (111-120 of 149) with videos related to
Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1992
Dihydrexidine, a novel full efficacy D1 dopamine receptor agonistD M Mottola, W K Brewster, L L Cook, et al.The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
Distinct recognition of substrates by the human and Drosophila serotonin transportersG J Rodríguez, D L Roman, K J White, et al.Psychopharmacology|January 1, 1991
Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonistsC W Callaway, M P Johnson, L H Gold, et al.Journal of Medicinal Chemistry|May 1, 1982
Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomesD E Nichols, D H Lloyd, A J Hoffman, et al.Analytical Chemistry|September 1, 1991
Silica subsurface amine effect on the chemical stability and chromatographic properties of end-capped immobilized artificial membrane surfacesR J Markovich, X X Qiu, D E Nichols, et al.Journal of Medicinal Chemistry|August 1, 1987
Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogueR M Riggs, D E Nichols, M M Foreman, et al.European Journal of Pharmacology|June 4, 1987
3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brainG A Ricaurte, K F Finnegan, D E Nichols, et al.Cellular and Molecular Neurobiology|July 7, 2001
The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissueJ E Sprague, T J Worst, K Haynes, et al.Journal of Medicinal Chemistry|March 26, 1999
Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamineJ B Blair, D Marona-Lewicka, A Kanthasamy, et al.Journal of Medicinal Chemistry|July 22, 1994
Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonistT A Knoerzer, D E Nichols, W K Brewster, et al.Pageof 15